sacituzumab govitecan,trastuzumab deruxtecan
gilead sciences,daiichi sankyo,astrazeneca
[' sg ', 'biomarker', 'breast']
adcs in metastatic breast cancer. lots of progress with tdxd and sg and now her3 dxd. yet, also key questions on why ag expression not a clear biomarkers, sequencing of adcs, chemo-like toxicity and ild. 
Breast Med Onc & Chief, Heme/Onc/Pall Care, UW Medicine & Carbone Cancer Center. Mom of 3. Enjoys travel, books, time w friends & family, volleyball and pets.